Evident LogoOlympus Logo

Pergunte a um especialista

Hiroya Ishihara
Hiroya Ishihara

Hiroya Ishihara

Applications Scientist

Mr. Hiroya Ishihara is an Application Scientist at Olympus. He was studying the epigenetic factors involved in plant regeneration using omics and microscopy in Tokyo University of Science. Confocal and two-photon microscopy were his trusted partner at that time. Therefore, he joined Olympus to make life science more exciting with microscopes. Currently, he is working on a wide range of projects from basic research to product/sales strategy.

Pergunte a um especialista:

Análise tridimensional de imagem de alta produtividade operacional de organoides e esferoides derivados do paciente.

Especialistas
Hiroya Ishihara
Applications Scientist
Olympus Technologies Asia, Olympus Corporation
Organoides e esferoides podem ser reproduzidos com mais fidelidade em condições in vivo, e a análise baseada em imagem pode monitorar respostas específicas a células com alta resolução espacial. Por este motivo, desenvolvemos análise tridimensional com base em imagem e métodos de avaliação de drogas usando organoides e esferoides derivados do paciente.
NoviSight™ Demonstration: 3D Image Analysis and Statistical Software for Organoids and Spheroids

NoviSight™ Demonstration: 3D Image Analysis and Statistical Software for Organoids and Spheroids

Especialistas
Hiroya Ishihara
Applications Scientist
Olympus Technologies Asia, Olympus Corporation
Three-dimensional cell culture models such as patient-derived organoids (PDO) and spheroids have increased in popularity because they can provide a 3D microenvironment that more closely reproduces in vivo conditions compared to 2D monolayer culture. Phenotypic and functional heterogeneity arise among cancer cells within the same tumor because of genetic change, environmental differences and reversible changes in cell properties. Therefore, evaluation of cell-specific responses is important for accurate prediction of drug efficacy and kinetics in vivo.
InSight Blog Sign-up

By clicking subscribe you are agreeing to our privacy policy which can be found here.

Sorry, this page is not
available in your country.

Desculpe, esta página não está disponível em seu país